Zepp Health Invests $2.4M to Lead neuro42's Series A Round

Zepp Health Corp. (NYSE: ZEPP), and neuro42, Inc. today announced that Zepp Health is investing $2.4 million to lead the $6.5 million Series A funding round for the development of MRI and robotics technology that allows physicians to diagnose brain injury in acute settings and treat neurological diseases under live imaging.
（以上内容由医药魔方AI生成）